51
|
Chen WL, Jin X, Wang M, Liu D, Luo Q, Tian H, Cai L, Meng L, Bi R, Wang L, Xie X, Yu G, Li L, Dong C, Cai Q, Jia W, Wei W, Jia L. GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling. JCI Insight 2020; 5:131596. [PMID: 32051337 DOI: 10.1172/jci.insight.131596] [Citation(s) in RCA: 43] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2019] [Accepted: 01/10/2020] [Indexed: 12/22/2022] Open
Abstract
Lung cancer (LC) is a leading cause of cancer-related deaths worldwide. Its rapid growth requires hyperactive catabolism of principal metabolic fuels. It is unclear whether fructose, an abundant sugar in current diets, is essential for LC. We demonstrated that, under the condition of coexistence of metabolic fuels in the body, fructose was readily used by LC cells in vivo as a glucose alternative via upregulating GLUT5, a major fructose transporter encoded by solute carrier family 2 member 5 (SLC2A5). Metabolomic profiling coupled with isotope tracing demonstrated that incorporated fructose was catabolized to fuel fatty acid synthesis and palmitoleic acid generation in particular to expedite LC growth in vivo. Both in vitro and in vivo supplement of palmitoleic acid could restore impaired LC propagation caused by SLC2A5 deletion. Furthermore, molecular mechanism investigation revealed that GLUT5-mediated fructose utilization was required to suppress AMPK and consequently activate mTORC1 activity to promote LC growth. As such, pharmacological blockade of in vivo fructose utilization using a GLUT5 inhibitor remarkably curtailed LC growth. Together, this study underscores the importance of in vivo fructose utilization mediated by GLUT5 in governing LC growth and highlights a promising strategy to treat LC by targeting GLUT5 to eliminate those fructose-addicted neoplastic cells.
Collapse
Affiliation(s)
- Wen-Lian Chen
- Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Xing Jin
- Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Mingsong Wang
- Department of Thoracic Cardiovascular Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Dan Liu
- Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Qin Luo
- Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Hechuan Tian
- Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Lili Cai
- Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Lifei Meng
- Department of Thoracic Cardiovascular Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Rui Bi
- Department of Thoracic Cardiovascular Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Lei Wang
- Department of Thoracic Cardiovascular Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Xiao Xie
- Department of Thoracic Cardiovascular Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Guanzhen Yu
- Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Lihui Li
- Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Changsheng Dong
- Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Qiliang Cai
- Ministry of Education and Ministry of Health Key Lab of Medical Molecular Virology, School of Basic Medical Science, Fudan University, Shanghai, China
| | - Wei Jia
- University of Hawaii Cancer Center, Honolulu, Hawaii, USA
| | - Wenyi Wei
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
| | - Lijun Jia
- Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| |
Collapse
|
52
|
Patel OV, Casey T, Plaut K. Profiling solute-carrier transporters in key metabolic tissues during the postpartum evolution of mammary epithelial cells from nonsecretory to secretory. Physiol Genomics 2019; 51:539-552. [PMID: 31545931 DOI: 10.1152/physiolgenomics.00058.2019] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Modifications in the abundance of solute-carrier (SLC) transcripts in tandem with adjustments in genes-associated with energy homeostasis during the postpartum transition of the mammary epithelial cells (MEC) from nonsecretory to secretory is pivotal for supporting milk synthesis. The goal of this study was to identify differentially expressed SLC genes across key metabolic tissues between late pregnancy and onset of lactation. Total RNA was isolated from the mammary, liver, and adipose tissues collected from rat dams on day 20 of pregnancy (P20) and day 1 of lactation (L1) and gene expression was measured with Rat 230 2.0 Affymetrix GeneChips. LIMMA was utilized to identify the differential gene expression patterns between P20 and L1 tissues. Transcripts engaged in conveying anions, cations, carboxylates, sugars, amino acids, metals, nucleosides, vitamins, and fatty acids were significantly increased (P < 0.05) in MEC during the P20 to L1 shift. Downregulated (P < 0.05) genes in the mammary during the physiological transition included GLUT8 and SLC45a3. In the liver, SLC genes encoding for anion, carbonyl, and nucleotide sugar transporters were upregulated (P < 0.05) at L1. while genes facilitating transportation of anions and hexose were increased (P < 0.05), from P20 to L1 in the adipose tissue. GLUT1 and GLUT4 in the liver, along with GLUT4 and SGLT2 in the adipose tissue, were repressed (P < 0.05) at L1. Our results illustrate that MEC exhibit dynamic molecular plasticity during the nonsecretory to secretory transition and increase biosynthetic capacity through a coordinated tissue specific SLC transcriptome modification to facilitate substrate transfer.
Collapse
Affiliation(s)
- Osman V Patel
- Department of Cell and Molecular Biology, Grand Valley State University, Allendale, Michigan
| | - Theresa Casey
- Department of Animal Sciences, Purdue University, West Lafayette, Indiana
| | - Karen Plaut
- Department of Animal Sciences, Purdue University, West Lafayette, Indiana
| |
Collapse
|
53
|
Jin C, Gong X, Shang Y. GLUT5 increases fructose utilization in ovarian cancer. Onco Targets Ther 2019; 12:5425-5436. [PMID: 31371983 PMCID: PMC6635899 DOI: 10.2147/ott.s205522] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2019] [Accepted: 06/20/2019] [Indexed: 01/01/2023] Open
Abstract
Background: Fructose is one of the most common dietary carbohydrates in the whole world, and recent studies have found that fructose consumption is closely related to the oncogenesis and development of tumors, however, very few studies have focused on the fructose in ovarian cancer. GLUT5 (Glucose transporter type 5), as a specific fructose transporter in mammalian cells, has also been found highly expressed in many cancers. Methods: In this study, we investigated the abilities of proliferation, colony formation, and migration of ovarian cancer cells in fructose medium, and then silenced GLUT5 in ovarian cancer cells to explore the role GLUT5 in fructose metabolism in ovarian cancer. Results: The results showed that the ovarian cancer cells had similar abilities of proliferation and migration in fructose medium and glucose medium, but silencing GLUT5 could significantly inhibit these abilities in fructose medium. Meanwhile, we found that GLUT5 was higher expressed in ovarian cancer tissues, and its expression correlated significantly with tumor malignancy and poor survival of ovarian cancer patients. Furthermore, the results of animal experiments also demonstrated that intake too much fructose could prominently increase tumor volume, and silencing GLUT5 could significantly inhibit tumor proliferation. Conclusion: In conclusion, we demonstrate that ovarian cancer cells could utilize fructose for their growth, and restricting the fructose intake or targeting GLUT5 may be efficacious strategies for ovarian cancer therapy.
Collapse
Affiliation(s)
- Cuiping Jin
- Department of Gynaecology and Obstetrics, Tianjin Hospital, Tianjin 300211, People's Republic of China
| | - Xiaojin Gong
- Department of Gynaecology and Obstetrics, Tianjin Hospital, Tianjin 300211, People's Republic of China
| | - Yumin Shang
- Department of Gynaecology and Obstetrics, Tianjin Hospital, Tianjin 300211, People's Republic of China
| |
Collapse
|
54
|
An essential role for GLUT5-mediated fructose utilization in exacerbating the malignancy of clear cell renal cell carcinoma. Cell Biol Toxicol 2019; 35:471-483. [PMID: 31102011 DOI: 10.1007/s10565-019-09478-4] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2019] [Accepted: 05/06/2019] [Indexed: 10/26/2022]
Abstract
Fructose is an important alternative carbon source for several tumors, and GLUT5 is the major fructose transporter which mediates most of fructose uptake in cells. So far, it is unclear whether GLUT5-mediated fructose utilization is important for clear cell renal cell carcinoma (ccRCC). Here, we demonstrated that GLUT5 was highly expressed in a panel of ccRCC cell lines. High GLUT5 expression exacerbated the neoplastic phenotypes of ccRCC cells, including cell proliferation and colony formation. On the other hand, deletion of the GLUT5-encoding gene SLC2A5 dramatically attenuated cellular malignancy via activating the apoptotic pathway. Moreover, administration of 2,5-anhydro-D-mannitol (2,5-AM), a competitive inhibitor of fructose uptake, could markedly suppress ccRCC cell growth. Together, we provide a new mechanistic insight for GLUT5-mediated fructose utilization in ccRCC cells and highlight the therapeutic potential for targeting this metabolic pathway against ccRCC.
Collapse
|
55
|
Lu M, Khine YY, Chen F, Cao C, Garvey CJ, Lu H, Stenzel MH. Sugar Concentration and Arrangement on the Surface of Glycopolymer Micelles Affect the Interaction with Cancer Cells. Biomacromolecules 2018; 20:273-284. [DOI: 10.1021/acs.biomac.8b01406] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Affiliation(s)
- Mingxia Lu
- Centre for Advanced Macromolecular Design (CAMD), School of Chemistry, University of New South Wales, Sydney NSW 2052, Australia
| | - Yee Yee Khine
- Centre for Advanced Macromolecular Design (CAMD), School of Chemistry, University of New South Wales, Sydney NSW 2052, Australia
| | - Fan Chen
- Centre for Advanced Macromolecular Design (CAMD), School of Chemistry, University of New South Wales, Sydney NSW 2052, Australia
| | - Cheng Cao
- Centre for Advanced Macromolecular Design (CAMD), School of Chemistry, University of New South Wales, Sydney NSW 2052, Australia
- Australia Nuclear Science and Technology Organisation, Lucas Heights, NSW 2234, Australia
| | - Christopher J. Garvey
- Australia Nuclear Science and Technology Organisation, Lucas Heights, NSW 2234, Australia
| | - Hongxu Lu
- Centre for Advanced Macromolecular Design (CAMD), School of Chemistry, University of New South Wales, Sydney NSW 2052, Australia
| | - Martina H. Stenzel
- Centre for Advanced Macromolecular Design (CAMD), School of Chemistry, University of New South Wales, Sydney NSW 2052, Australia
| |
Collapse
|
56
|
Zhao P, Huang J, Zhang D, Zhang D, Wang F, Qu Y, Guo T, Qin Y, Wei J, Niu T, Zheng Y. SLC2A5
overexpression in childhood philadelphia chromosome-positive acute lymphoblastic leukaemia. Br J Haematol 2018; 183:242-250. [PMID: 30272826 DOI: 10.1111/bjh.15580] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2018] [Accepted: 07/29/2018] [Indexed: 02/05/2023]
Affiliation(s)
- Pan Zhao
- Department of Haematology; West China Hospital; Sichuan University; Chengdu China
- Department of Haematology; Affiliated Hospital of North Sichuan Medical College; Chengdu China
- State Key Laboratory of Biotherapy and Cancer Centre; West China Hospital; Sichuan University; Chengdu China
| | - Jingcao Huang
- Department of Haematology; West China Hospital; Sichuan University; Chengdu China
| | - Dan Zhang
- Department of Haematology; West China Hospital; Sichuan University; Chengdu China
| | - Danfeng Zhang
- Department of Haematology; West China Hospital; Sichuan University; Chengdu China
| | - Fangfang Wang
- Department of Haematology; West China Hospital; Sichuan University; Chengdu China
| | - Ying Qu
- Department of Haematology; West China Hospital; Sichuan University; Chengdu China
| | - Tingting Guo
- Department of Haematology; West China Hospital; Sichuan University; Chengdu China
| | - Yu Qin
- Department of Endocrinology; Baylor College of Medicine; Houston TX USA
| | - Jin Wei
- Department of Haematology; Affiliated Hospital of North Sichuan Medical College; Chengdu China
| | - Ting Niu
- Department of Haematology; West China Hospital; Sichuan University; Chengdu China
| | - Yuhuan Zheng
- Department of Haematology; West China Hospital; Sichuan University; Chengdu China
- State Key Laboratory of Biotherapy and Cancer Centre; West China Hospital; Sichuan University; Chengdu China
| |
Collapse
|
57
|
Weng Y, Zhu J, Chen Z, Fu J, Zhang F. Fructose fuels lung adenocarcinoma through GLUT5. Cell Death Dis 2018; 9:557. [PMID: 29748554 PMCID: PMC5945656 DOI: 10.1038/s41419-018-0630-x] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2018] [Revised: 04/21/2018] [Accepted: 04/24/2018] [Indexed: 02/07/2023]
Affiliation(s)
- Yuanyuan Weng
- Core Facility, Department of Clinical Laboratory, Quzhou People's Hospital, Quzhou, Zhejiang, China
| | - Jin Zhu
- Core Facility, Department of Clinical Laboratory, Quzhou People's Hospital, Quzhou, Zhejiang, China
| | - Zhenhong Chen
- Department of Oncology, Quzhou People's Hospital, Quzhou, Zhejiang, China
| | - Jingqi Fu
- Program of Environmental Toxicology, School of Public Health, China Medical University, Shenyang, China
| | - Feng Zhang
- Core Facility, Department of Clinical Laboratory, Quzhou People's Hospital, Quzhou, Zhejiang, China.
| |
Collapse
|